Skip to main content

CTOS 2025 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Christopher W. Ryan, MD

OHSU Knight Cancer Institute, South Waterfront

Poster(s):

(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES